Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Different Modified Atmosphere Packaging on the Quality of Mulberry Fruit (Morus alba L. cv Kokuso 21). | Int J Food Sci | 2021 | 33614781 | PubTator, text mining | PubMed |
| Protocol to prepare functional cellular nanovesicles with PD1 and TRAIL to boost antitumor response. | STAR Protoc | 2021 | 33604583 | PubTator, text mining | PubMed |
| Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. | Trends Pharmacol Sci | 2021 | 33581873 | PubTator, text mining | PubMed |
| Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. | BMJ | 2021 | 33574135 | PubTator, text mining | PubMed |
Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages Isolated from Sprague-Dawley Rats by Regulating NF-κB/NFATc1 and Akt/NFATc1 Signaling Pathways. | Cell Transplant | 2021 | 33573387 | PubTator, text mining | PubMed |
| The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists. | Int J Gynecol Pathol | 2021 | 33570867 | PubTator, text mining | PubMed |
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced. | RMD Open | 2021 | 33568556 | PubTator, text mining | PubMed |
| CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. | Int J Nanomedicine | 2021 | 33542625 | PubTator, text mining | PubMed |
| DNA methylation impact on Fabry disease. | Clin Epigenetics | 2021 | 33531072 | PubTator, text mining | PubMed |
| Relationships between serum electrolyte concentrations and ileus: A joint clinical and mathematical modeling study. | Physiol Rep | 2021 | 33527737 | PubTator, text mining | PubMed |
| Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. | Int J Mol Sci | 2021 | 33525510 | PubTator, text mining | PubMed |
| Ubrogepant to Treat Acute Migraine in Adults. | Neurol Int | 2021 | 33525313 | PubTator, text mining | PubMed |
| In-silico network-based analysis of drugs used against COVID-19: Human well-being study. | Saudi J Biol Sci | 2021 | 33519272 | PubTator, text mining | PubMed |
| Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte cultures. | FEBS Open Bio | 2021 | 33512765 | PubTator, text mining | PubMed |
| A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma. | Dis Markers | 2021 | 33510822 | PubTator, text mining | PubMed |
| Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics. | Genes (Basel) | 2021 | 33504001 | PubTator, text mining | PubMed |
| The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. | Cell Death Dis | 2021 | 33500395 | PubTator, text mining | PubMed |
| Is the US failing women? | EClinicalMedicine | 2021 | 33490929 | PubTator, text mining | PubMed |
| Zinc transporters and their functional integration in mammalian cells. | J Biol Chem | 2021 | 33485965 | PubTator, text mining | PubMed |
| Ethylene and Sulfur Coordinately Modulate the Antioxidant System and ABA Accumulation in Mustard Plants under Salt Stress. | Plants (Basel) | 2021 | 33478097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=66